Immix Biopharma, Inc.

IMMX

—

Advanced chart & tools →

Immix Biopharma, Inc.IMMX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-0.89

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$20.00M

Net income

$-29.44M

Net margin

-147.2%

Gross margin

—

Dividends & financials

Immix Biopharma, Inc. (IMMX) reported revenue of $20.00M and net income of $-29.44M, or $-0.89 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.